Cytara1000mg/vial

Cytarabine is used to treat some kinds of cancers of blood. It may be also used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy. Cytarabine is given as an injection into the vein or under skin by the healthcare professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. The most common side effects of this medicine include rash, skin ulcer, nausea, vomiting, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections or bleeding. Inform your doctor if you notice chills, unusual bleeding or bruising and black and tarry stools. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. Before taking it, tell your doctor if you have bleeding, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. Cytarabine interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.

• Blood cancer

Cytarabine acts by interfering with DNA synthesis specifically at the S-phase of the cell cycle. It is a potent myelosuppressant and requires careful haematological monitoring during its use. It also has antiviral property.

Adult Dose: Acute Nonlymphocytic Leukemia IV administration for remission induction 100-200 mg/sq.meter/day for 5-10 days; begin second course in 2-4 weeks after initial therapy if necessary OR 100 mg/sq.meter for 7 days OR 100 mg/sq.meter/dose q12hr for 7 days Intrathecal (IT) administration for remission induction 5-75 mg/sq.meter q2-7Days until CNS findings normalize IV administration for remission maintenance 70-200 mg/sq.meter/day for 2-5 days at monthly intervals IM administration for remission maintenance 1-1.5 mg/kg single dose for maintenance at 1- 4 week intervals Meningeal Leukemia IT administration 30 mg/sq.meter intrathecal (IT) q4Days until CSF findings normal plus one additional dose Refractory Leukemia IV administration 3 g/sq.meter IV (infusion over 1-3 hours) q12hr x 4-12 doses Repeat q2-3Weeks

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Common: • Rash • Skin ulcer • Nausea • Vomiting • Hair loss • Abdominal pain • Anal ulcers • Anemia (low number of red blood cells) • Decreased white blood cell count • Fever • Infection • Abnormal liver function • Low blood platelets • Mouth ulcer • Pneumonia • Sepsis • Mouth sore • Stomatitis (Inflammation of the mouth)

[UNSAFE] Cytarabine may cause side effects which could affect your ability to drive. Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine. Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.

Hypersensitivity; pregnancy and lactation.

May reduce efficacy of gentamicin, digoxin and flucytosine. Potentially Fatal: Potentiates bone marrow depression with radiotherapy and other myelotoxic drugs.

[CONSULT YOUR DOCTOR] It is not known whether it is safe to consume alcohol with Cytarabine. Please consult your doctor.

[CONSULT YOUR DOCTOR] Cytarabine is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

[UNSAFE] Cytarabine is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

[SAFE IF PRESCRIBED] Cytarabine is safe to use in patients with kidney disease. No dose adjustment of Cytarabine is recommended. However, talk to your doctor if you have any underlying kidney disease. [CONSULT YOUR DOCTOR] There is limited information available on the use of Cytarabine in patients with liver disease. Please consult your doctor. Because of the limited information, a cautious use of Cytarabine is recommended in patients with liver disease.

Can blood cancer patients 1st stage do sex with normal girl Sir a blood cancer patients do sex with normal girl can any problem or cause doing with girl or side effect give suggestions Thanks Wait till blood cancer gets cured. Blood Cancer. Is there any medicine to cure blood cancer. Case has to be seen in person What is t-cell all ??? And treatment This is my mother first born mero report Now the blast is less then 5% after 1 month treatment This is blood cancerShe is in remission I seem to have lung cancer , becoz all the symptoms are same as lung cancer. I test my blood, they suggests me that it is highly probable to lung cancer. Sir what can i do now. This is in preliminary stage Do you think that lung cancer is diagnosed from blood please tell me the symptoms of blood cancer Blood cancer can have following symptoms Fever Bleeding Lymphadenopathy Patechia How to come blood. Cancer ,,,, Dear PATIENT specify your question. What is the complete treatment for blood cancer Blood cancer has 4 types, do you know which type u r asking Medicine for first stage blood cancer Need to consult face to face , kindly consult to ayurvedic doctor at your local city.